Randomized trial · people
NMN raised muscle insulin sensitivity in women with prediabetes
Checked against the paper Randomized trialPublished by PepVault
The takeaway
This is a placebo-controlled human trial where NMN improved how muscle responds to insulin in women with prediabetes, over 10 weeks.
- Kind
- Randomized trial
- Studied in
- People
- Published
- 2021
- Journal
- Science
What they tested
The team tested whether taking NMN, a building block the body needs to make NAD+, improves metabolic health in women with prediabetes.
How the study was done
A 10-week randomized, double-blind, placebo-controlled trial in women past menopause who had prediabetes and carried extra weight, from overweight to obesity. Neither the women nor the researchers knew who got NMN and who got placebo (a dummy treatment).

What they found
Insulin-driven glucose uptake went up after NMN and did not change after placebo. This was measured with a hyperinsulinemic-euglycemic clamp, a lab test of how well insulin clears sugar from the blood. Insulin signaling inside skeletal muscle also rose with NMN, based on the activation of two proteins, AKT and mTOR. NMN also turned up platelet-derived growth factor receptor β and other genes linked to muscle remodeling.
What it doesn’t show
It was a short 10-week trial in one narrow group, postmenopausal women with prediabetes and excess weight, so it doesn't show what happens in men, in younger people or over longer periods. It measured insulin sensitivity and muscle signaling, not whether the women went on to develop diabetes.
The paper
Yoshino et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.
The compounds
More studies on NAD+
- NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 daysRandomized trial · people · 2026
- NMN raised serum nicotinamide over 12 weeks in middle-aged adultsRandomized trial · people · 2023
- NMN supplements raised blood NAD+ levels in healthy older menRandomized trial · people · 2022
- NAD+ rose with nicotinamide riboside in a 6-week crossover trialRandomized trial · people · 2018
- Every study on NAD+
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.